
In the final part of this three-part conversation, Liam and Ted close things out with Scott Burgher, Director of Patient Operations at Quest Diagnostics, looking ahead at where AI genuinely moves the needle in recruitment, and where the industry still gets feasibility wrong. Scott breaks AI's near-term impact into two practical buckets. The first is administrative: compressing study startup from six to twelve months down to weeks by automating document collection, regulatory submissions, IRB...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Ep 2.29: "That's Not a Performance Problem, It's a Structural One" Scott Burgher on Why Sites Stop Recruiting (Part 2/3)

Ep 2.28 Scott Burgher on Why 86% of Trials Miss Their Enrollment Deadline (Part 1/3)

Ep 2.27: 31 Years of Clinical Trials, Here's What Ted Trafford Knows for Sure

Ep 2.29: Lasagna's Law and Building Recruitment Forecasts You Can Actually Trust
Free AI-powered recaps of Innovating Clinical Trials and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.